GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (FRA:7UM0) » Definitions » Cash Receipts from Loans

Zelluna ASA (FRA:7UM0) Cash Receipts from Loans


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Cash Receipts from Loans?

Cash Receipts from Loans only applicable to companies reporting Cash Flow from Operations in direct method.


Zelluna ASA Business Description

Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.